Cognitive Behavioural Therapy for Inflammatory Bowel Disease
(iCBT Trial)
Trial Summary
What is the purpose of this trial?
The study will examine the efficacy of an internet-based cognitive behavioural therapy (iCBT) for Inflammatory Bowel Disease (IBD) intervention to reduce stress, anxiety, and depression in individuals with IBD and comorbid clinically elevated t anxiety and/or depressive symptoms. The investigators will conduct a two-arm RCT comparing participants receiving the iCBT intervention (intervention group) and those receiving Treatment As Usual (TAU).
Research Team
Eligibility Criteria
This trial is for adults over 18 with Inflammatory Bowel Disease (IBD) who are experiencing stress, anxiety, or depression. Participants must have an IBD diagnosis from a doctor, score above 8 on specific anxiety/depression scales, and have stable psychotropic medication for six weeks before joining. They need computer access and English literacy but can't join if they've had recent severe mental health issues or current/recent CBT treatment.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Cognitive Behavioural Therapy (Behavioral)
Cognitive Behavioural Therapy is already approved in Canada for the following indications:
- Anxiety disorders
- Substance use disorders
- Depression
- Post-traumatic stress disorder (PTSD)
- Eating disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor
Charles Semba
University of Manitoba
Chief Medical Officer since 2020
MD from the University of Minnesota Medical School
Rick Pauls
University of Manitoba
Chief Executive Officer since 2010
Bachelor of Arts in Economics from the University of Manitoba, MBA in Finance from the University of North Dakota